Friday, August 22, 2025

A Heart Disease Cure For Pericarditis? Phase 3 Trial Advances | David Elsley – Cardiol Therapeutics

FULL DISCLOSURE: This is sponsored content for Cardiol Therapeutics.

Discover the major breakthrough at Cardiol Therapeutics (NASDAQ: CRDL) (TSX: CRDL) as CEO David Elsley reveals the enrollment of their first patient in the pivotal Phase 3 MAVERIC trial for recurrent pericarditis. In this concise interview, Elsley discusses how their oral drug therapy aims to prevent new episodes of this debilitating heart condition, the impressive Phase 2 results showing significant pain reduction, and the potential timeline for market entry by mid-2026.

With trial sites at prestigious institutions like Mass General, Cleveland Clinic, and Mayo Clinic, and a market potential approaching $1 billion by 2028, investors won’t want to miss this significant development in cardiovascular medicine.


FULL DISCLOSURE: Cardiol Therapeutics is a client of Canacom Group, the parent company of The Deep Dive. Canacom Group is currently long the equity of Cardiol Therapeutics. The author has been compensated to cover Cardiol Therapeutics on The Deep Dive, with The Deep Dive having full editorial control. Not a recommendation to buy or sell. We may buy or sell securities in the company at any time. Always do additional research and consult a professional before purchasing a security.

Video Articles

A Medical Breakthrough the Market Overlooked | David Elsley – Cardiol Therapeutics

Why Grade Beats Size in Silver Mining | Frank Basa – Nord Precious Metals

Are Investors Missing the Start of the Next Commodity Supercycle? | Morgan Lekstrom – NexMetals

Recommended

Emerita Resources Expands El Cura Drill Program By 10,000 Metres As Deposit Remains Open For Expansion

ESGold Signs MOU For Tailings Project In Colombia With Grades Up To 42 g/t Gold, 280 g/t Silver

Related News

Society is Becoming Unstable: From Meme Coin Hysteria to Mining’s Next Bull Run | Doug Casey

In this interview, Doug Casey provides wide-ranging insights on current events and investment opportunities, drawing...

Saturday, December 21, 2024, 01:38:00 PM

Global Copper Stockpiles Are Falling — With Craig Hemke

Back on the Daily Dive today is Craig Hemke, founder of the TF Metals Report....

Wednesday, February 22, 2023, 01:33:20 PM

Gold Streaming Companies Are More Profitable Than Producers – The Daily Dive

On today’s Daily Dive, Cassandra sits down with Michael Matousek of US Global Investors. He...

Wednesday, September 8, 2021, 01:30:00 PM

Gold To $2500 By Mid-2021? – The Daily Dive feat Tom Meredith

The Daily Dive today is featuring that of Tom Meredith, Executive Chairman of West Red...

Wednesday, November 11, 2020, 01:09:17 PM

John-Mark Staude: Bullish On Uranium & Other Green Metals – The Daily Dive

On today’s Daily Dive, we welcome back John-Mark Staude, CEO of Riverside Resources (TSXV: RRI)....

Monday, September 20, 2021, 01:30:00 PM